Market Brief
Billion Doses of Novavax COVID-19 Vaccine to be Produced in Czech Republic, an Industrial Info Market Brief
According to idnes.cz news portal, Novavax plans to produce over a billion doses of new COVID-19 vaccine at a recently bought plant in Czech Republic. The plant is undergoing an expansion. Currently, clinical trials are ongoing.
Released Wednesday, September 02, 2020
Reports related to this article:
According to idnes.cz news portal, Novavax plans to produce over a billion doses of new COVID-19 vaccine at a recently bought plant in Czech Republic. The plant is undergoing an expansion. Currently, clinical trials are ongoing.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Africa's Fertilizer Demand Sparks $5.8 Billion of ProjectsApril 28, 2021
-
Poland's PGE Plans $7 Billion Renewable Energy PushApril 28, 2021
-
Industrial Construction Activity Up 37% So Far in 2021April 26, 2021
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
Brazil Critical Minerals 2027: Rare Earths, Lithium, CopperPodcast Episode / Oct 16, 2026
-
US Craft Labor Outlook 2026: Wages, Per Diems, Data CentersPodcast Episode / Oct 16, 2026
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
